Search Within

Neuro-Oncology Service

Formats
  1. Journal Article (426)
  2. Meeting Abstract (297)
  3. Book Section (22)
  4. Editorial (13)
  5. Review (8)
  6. Research Letter (5)
  7. Conference Paper (4)
  8. Correspondence (3)
  9. Guidelines (3)
Groups
  1. Pediatrics, Department of (781)
  2. Survivorship Research (436)
  3. GSK Faculty (231)
  4. Tow Center for Developmental Oncology (TCDO) (224)
  5. Neuroblastoma Service (200)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (198)

More Groups

People
  1. Ira Dunkel (372)
  2. Kim Kramer (237)
  3. Nai-Kong Cheung (168)
  4. Yasmin Khakoo (149)
  5. Matthias Karajannis (142)
  6. Brian Kushner (136)

More People

Years
  1. 2025 (11)
  2. 2024 (34)
  3. 2023 (43)
  4. 2022 (47)
  5. 2021 (44)
  6. 2020 (53)

More Years

Publications
  1. Neuro-Oncology (176)
  2. Pediatric Blood and Cancer (115)
  3. Journal of Clinical Oncology (63)
  4. Journal of Neuro-Oncology (26)
  5. International Journal of Radiation Oncology, Biology, Physics (18)
  6. Cancer (17)

More Publications

Publishers
  1. Oxford University Press (192)
  2. Wiley Periodicals, Inc (115)
  3. American Society of Clinical Oncology (67)
  4. Elsevier Inc. (54)
  5. Springer (53)
  6. American Association for Cancer Research (29)

More Publishers

Results (781)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive diagnosis of gliomas through CSF CFDNA sequencing in pediatric and adolescent and young adult (AYA) patients
    Meeting Abstract

    Hill, K.; Miller, A. M.; Li, B. K.; Bouvier, N.; Li, S.; Alano, T.; Doe-Tetteh, S.; Huereca, C.; DiNapoli, S.; Lee, A.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?
    Meeting Abstract

    Erker, C.; Craig, B.; Bailey, S.; Massimino, M.; Larouche, V.; Finlay, J. L.; Kline, C.; Michaiel, G.; Margol, A.; Cohen, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
    Meeting Abstract

    Kolodziejczak, A.; Guerrini-Rousseau, L.; Planchon, J. M.; Ecker, J.; Selt, F.; Mynarek, M.; Obrecht, D.; Sill, M.; Hirsch, S.; Sturm, D.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Radiation induced high grade gliomas: A single center experience
    Meeting Abstract

    Joshirao, M.; Sait, S. F.; Bouvier, N.; Hill, K.; Khakoo, Y.; Kramer, K.; Gilheeney, S.; Wolden, S.; Nolan, C.; Schaff, L.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908
    Meeting Abstract

    Dunkel, I. J.; Cohen, K.; Foreman, N. K.; Hargrave, D.; Lassaletta, A.; AndreĢ, N.; Hansford, J. R.; Hassall, T.; Eyrich, M.; Gururangan, S.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Selumetinib in pediatric patients with non-neurofibromatosis type 1-associated, nonoptic pathway (OPG) and non-pilocytic recurrent/ progressive low-grade glioma harboring BRAFV600E mutation or BRAF-KIAA1549 fusion: A multicenter prospective Pediatric Brain Tumor Consortium (PBTC) phase 2 trial
    Meeting Abstract

    Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Lensing, S.; Wu, S.; Ligon, A. H.; Lindeman, N.; Stewart, C. F.; Jones, D. T. W.; Pfister, S. M.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Pediatric Brain Tumor Consortium (PBTC)-055: A phase I study of trametinib and hydroxychloroquine (HCQ) for BRAF-fusion or neurofibromatosis type-1 (NF1)-associated pediatric gliomas
    Meeting Abstract

    Hoffman, L. M.; Levy, J. M.; Kilburn, L.; Billups, C.; Stokes, V.; McCourt, E.; Poussaint, T. Y.; Campagne, O.; Partap, S.; Dorris, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 study of veliparib and local irradiation, followed by maintenance veliparib and temozolomide, in patients with newly diagnosed highgrade glioma without H3 K27M or BRAF Mutations: A report from the Children's Oncology Group ACNS1721 study
    Meeting Abstract

    Karajannis, M.; Onar-Thomas, A.; Baxter, P.; Butingan, N.; Fuller, C.; Gajjar, A.; Haque, S.; Jabado, N.; Lin, T.; Lucas, J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Neurocutaneous melanocytosis-associated hydrocephalus: The MSK experience from 2001-2022
    Meeting Abstract

    Rodriguez, S.; Sener, U.; Elmore, K.; Haque, S.; Suser, S.; Greenfield, J.; Donzelli, M.; DePass, C.; Pugh, J.; Porter, J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save